Skip to main content
Premium Trial:

Request an Annual Quote

Genometrix to Provide SNP-Detection Services to Agouron

NEW YORK, March 28 – Genometrix of The Woodlands, Texas, said Wednesday it had reached an agreement to provide SNP-discovery services for Agouron Pharmaceuticals, a subsidiary of Pfizer.

Genometrix did not disclose the terms of the deal, which resulted following a SNP-discovery pilot project.

Spokespeople for Genometrix and Agouron were not immediately available for comment.

Genometrix studies samples provided by its customers, analyzing them using its VistaMorph genotyping technology and its VistaLogic analysis and visualization tools.

SNPs are then screened against the company’s Population Diversity Panel to determine the distribution of the alleles in a diverse population.

Recently, Genometrix also signed animal genomics company AniGenics, as a customer. The company’s other customers include Schering-Plough, Proctor and Gamble, and VistaGen. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.